BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21426562)

  • 21. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas.
    Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR
    J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.
    Kesic V; Carcopino X; Preti M; Vieira-Baptista P; Bevilacqua F; Bornstein J; Chargari C; Cruickshank M; Erzeneoglu E; Gallio N; Gultekin M; Heller D; Joura E; Kyrgiou M; Madić T; Planchamp F; Regauer S; Reich O; Esat Temiz B; Woelber L; Zodzika J; Stockdale C
    J Low Genit Tract Dis; 2023 Apr; 27(2):131-145. PubMed ID: 36951985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
    de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
    Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
    Garland SM; Joura EA; Ault KA; Bosch FX; Brown DR; Castellsagué X; Ferenczy A; Ferris DG; Giuliano AR; Hernandez-Avila M; Huh WK; Iversen OE; Kjaer SK; Kurman RJ; Luna J; Monsonego J; Muñoz N; Paavonen J; Pitisuttihum P; Ronnett BM; Steben M; Stoler MH; Wheeler CM; Wiley DJ; Perez G; Saah AJ; Luxembourg A; Li S; DiNubile MJ; Wagner M; Velicer C
    Obstet Gynecol; 2018 Aug; 132(2):261-270. PubMed ID: 29995724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
    Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
    Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
    Jamieson DJ; Paramsothy P; Cu-Uvin S; Duerr A;
    Obstet Gynecol; 2006 May; 107(5):1023-8. PubMed ID: 16648406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of cytology and HPV genotypes results of 3229 vaginal intraepithelial neoplasia patients.
    Ao M; Zheng D; Wang J; Gu X; Xi M
    J Med Virol; 2022 Feb; 94(2):737-744. PubMed ID: 34460120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
    Muderspach L; Wilczynski S; Roman L; Bade L; Felix J; Small LA; Kast WM; Fascio G; Marty V; Weber J
    Clin Cancer Res; 2000 Sep; 6(9):3406-16. PubMed ID: 10999722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The health care costs of cervical human papillomavirus--related disease.
    Insinga RP; Glass AG; Rush BB
    Am J Obstet Gynecol; 2004 Jul; 191(1):114-20. PubMed ID: 15295351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study.
    Buchanan TR; Zamorano AS; Massad LS; Liu J; Thaker PH; Powell MA; Mutch DG; Kuroki LM
    Gynecol Oncol; 2019 Oct; 155(1):88-92. PubMed ID: 31375270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
    Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
    Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
    Choi I; Lee D; Son KB; Bae S
    BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coexistence of VIN and vulvar invasive cancer with intraepithelial neoplasia and invasive carcinoma of the cervix and/or vagina, and HPV infection of the low female genital tract].
    Adamek K; Szczudrawa A; Basta A
    Ginekol Pol; 2003 Sep; 74(9):657-61. PubMed ID: 14674103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalization burden associated with malignant neoplasia and in situ carcinoma in vulva and vagina during a 5-year period (2009-2013) in Spain: An epidemiological study.
    López N; Gil-de-Miguel Á; Pascual-García R; Ramón Y Cajal JM; Gil-Prieto R
    Papillomavirus Res; 2018 Jun; 5():80-86. PubMed ID: 29458181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The costs of treating vaginal and vulval cancer in England (2009-2015).
    Stephens S; Chatterjee A; Coles V; Crawford R
    BMC Public Health; 2020 Apr; 20(1):453. PubMed ID: 32252711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulvar and Vaginal Cancer, Vulvar Intraepithelial Neoplasia 3 and Vaginal Intraepithelial Neoplasia 3: Experience of a Referral Institute.
    Siegler E; Segev Y; Mackuli L; Auslender R; Shiner M; Lavie O
    Isr Med Assoc J; 2016 May; 18(5):286-9. PubMed ID: 27430086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal intraepithelial neoplasia: a therapeutical dilemma.
    Frega A; Sopracordevole F; Assorgi C; Lombardi D; DE Sanctis V; Catalano A; Matteucci E; Milazzo GN; Ricciardi E; Moscarini M
    Anticancer Res; 2013 Jan; 33(1):29-38. PubMed ID: 23267125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
    Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
    Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.